Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant. Chen G, Herr M, Nowak J, Ho C, et al. Haematologica 2023;108:615-620.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen G, Herr M, Nowak J, Ho C, et al. Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant. Haematologica 2023;108:615-620.
PMID: 36263844